Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 231 - 239 of 239 results

First page
Previous page
24
Next page disabled
Next page disabled

INFLUENZA A VIRUS A/VIETNAM/1203/2004 (H5N1, CLADE 1) ANTIGEN (FORMALDEHYDE INACTIVATED)

3L2F8AM65K

Status:

US Previously Marketed

Source:

INFLUENZA VIRUS VACCINE, H5N1 by SANOFI PASTEUR INC

(2007)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2007

Source:

INFLUENZA VIRUS VACCINE, H5N1 by SANOFI PASTEUR INC

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) antigen (propiolactone inactivated)

PRE3ERF7G4

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a06c4ead-c988-4b10-b832-4d7460fa358f

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a06c4ead-c988-4b10-b832-4d7460fa358f

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED)

5UFQ6ZRS6Y

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a06c4ead-c988-4b10-b832-4d7460fa358f

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a06c4ead-c988-4b10-b832-4d7460fa358f

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)

A5WLI8WK8A

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED)

MS1B94SD2A

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)

9JWN7VDQ7N

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (PROPIOLACTONE INACTIVATED)

KFX1673OOP

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)

5087BPO79O

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)

BH0R06YXFZ

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

INFLUENZA A VIRUS A/VIETNAM/1203/2004 (H5N1, CLADE 1) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) antigen (propiolactone inactivated)

Structurally Diverse

INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)

Showing 231 - 239 of 239 results

First page
Previous page
24
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1